LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Fatty Liver
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Primarily in female mice, hepatic cholesterol accumulation induced by SCP-2 overexpression was associated with increased levels of LDL-receptor, HDL-receptor scavenger receptor-B1 (SR-B1) (as well as PDZK1 and/or membrane-associated protein 17 kDa), SCP-2, liver fatty acid binding protein (L-FABP), and 3alpha-hydroxysteroid dehydrogenase, without alteration of other proteins involved in cholesterol uptake (caveolin), esterification (ACAT2), efflux (ATP binding cassette A-1 receptor, ABCG5/8, and apolipoprotein A1), or oxidation/transport of bile salts (cholesterol 7alpha-hydroxylase, sterol 27alpha-hydroxylase, Na(+)/taurocholate cotransporter, Oatp1a1, and Oatp1a4).
|
19289417 |
2009 |
Non-alcoholic Fatty Liver Disease
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Based on the results, the promoting effects of EPA-PC on NAFLD may be partly associated with the suppression of cholesterol synthesis via HMGR inhibition and the enhancement of fecal cholesterol excretion through increased SCP2 transcription.
|
28012135 |
2017 |
Cholesterol gallstones
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Moreover, SCP2 was expressed at higher levels in hereditary cholesterol gallstone patients than that of non-hereditary cholesterol gallstone patients.
|
21310066 |
2011 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The sterol carrier protein SCP-x/pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase.
|
17485462 |
2007 |
Hypercholesterolemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In vivo, SCP2 overexpression and high cholesterol diet could promote tumor growth.
|
31519191 |
2019 |
Pituitary Adenoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Forced expression of SCP2 promoted PA cell lines proliferation in vitro.
|
31519191 |
2019 |
Diabetes Mellitus, Experimental
|
0.200 |
Therapeutic
|
disease |
RGD |
Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat.
|
7628371 |
1995 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SCP2 mutations and neurodegeneration with brain iron accumulation.
|
26497993 |
2015 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Leukoencephalopathy
|
0.400 |
Biomarker
|
group |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Leukoencephalopathy
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
BEFREE |
The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGFβ and the protein expression levels were measured by Western blot.
|
22995475 |
2012 |
Dystonia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Polyneuropathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Polyneuropathy, Motor
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia, Paroxysmal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia, Diurnal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Polyneuropathy, Critical Illness
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia, Limb
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Polyneuropathy, Familial
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Acquired Polyneuropathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |